|
Selected Projects...
|
- Provided strategic and operational support to public US medtech company for international business strategy, technology partnering and product licensing
- Provided planing and project management support for biologics drug development to Russian company
- Provided strategic support to public European biotech company for defining licensing framework and terms for platform technology and derived products
- Identified clinical stage licensing opportunities for public US biopharmaceutical company
- Supported US bioinformatics company in European marketing & licensing activities, identified and won severla European licensees
- Supported international provider of research products and services in European marketing & sales activities
- Identified European licensee for antibody technology from US company and supported negotiations and closing of licensing agreement
- Provided strategic and operational support for business plan and round A financing to U.S. company for late stage clinical project
- Generated shortlist of potential licensing partners for new formulation of known drug for European small pharma company
- Revised information material for cancer antibodies from U.S. biotech company to initiate partnering campaign
- Identified global pharma company as licensing partner for U.S. biotech company and provided communication, negotiation and term sheet drafting support
- Identified German co-development partner for U.S. company in the field of new antibody production technology
- Analyzed scientific, market and competitor situation for new peptide drug from European biotech company, acting on validated drug target, in hematologic disease indication
- Analyzed antibody generation and optimization technolgies, IP landscape, market and competitors for a European biotech company, performed freedom to operate analysis and provided strategic plan to enter this market
- Supported in-/out-licensing activities of Japanese/U.S. pharma company (identifying opportunities, contacting & follow-up, presentation material, due diligence, term sheet drafting)
- Supported insolvent Swiss and German biotech companies in trade sale activities (target screening, shortlist, contacting & follow-up)
- Identifed international pharma company as technology licensee for U.S. biotech company (screening, contacting & follow-up, negotiation strategy and contract drafting support)
- Organized and executed out-licensing campaign for validated cancer target and preclinical drug candidates from Swiss biotech company (documentation material, partner screening & shortlisting, contacting, follow-up, term sheet negotiations)
- Organized and executed out-licensing campaign for preclinical peptide drug candidates from German biotech company (documentation material, partner screening & shortlisting, contacting, follow-up)
- Identified and contacted potential licensing/co-development partners for technology, preclinical and clinical products from German biotech company (presentation material, partner screening & shortlisting, contacting, follow-up)
- Prepared licensing dossiers for targeted drugs in preclinical and clinical phases for German biotech company
- Prepared business plan and investor presentation for round B financing of product-focused German biotech company (conceptualization, writing, design and production)
- Represented various European biotech companies at partnering forum of international business conferences (material preparation, partner screening & shortlisting, scheduling, presentations, meeting summaries, follow-up)
|
|
|